Acadian Asset Management
CASC

Acadian Asset Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Acadian Asset Management’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-57,525
Closed -$238K – 1719
2017
Q1 		$238K Buy
+57,525
New +$238K ﹤0.01% 1018